Hot Investor Mandate 1: Global VC Invests Up to $10M in Novel Software-Based Healthcare Technologies with Focus in North America

22 Feb

A venture capital firm with a global presence invests in several verticals with the core interest being in scalable, breakthrough technologies. Initial investments may range from $100k – $1M, with up to $10M being invested over the life of the investment, in the form of convertible notes or straight equity. The firm will lead investments or co-invest as a syndicate. The firm will invest in companies on a global basis but is focused on companies in the U.S. and Canada. The partners and advisors of the fund look to add value to portfolio companies through an extensive international network and strong technical expertise.

The firm is generally agnostic to industry and is most interested in unique/novel technologies, with a special interest in AI and blockchain solutions in the healthcare space. While the group is primarily interested in software-based technologies, whether in drug discovery, enterprise software, digital health, etc., medical devices that do not require a traditional regulatory pathway (510(k) or PMA) and that have a core software component will also be considered.

The firm has no strict company or management team requirements and looks to mentor companies/management teams. The firm does not require a board seat along with an investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: